Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta-analysis.
Taro KishiKenji SakumaTakeo SaitoAtsuo NakagawaMasaki KatoNakao IwataPublished in: Neuropsychopharmacology reports (2024)
Overall BRE showed similar utility to ARI and a good risk-benefit balance.